Shall we really say goodbye to first rank symptoms?

European Psychiatry

Volumn 37, Issue , 2016, Pages 8-13

  Heinz, A ^a   Voss, M ^a   Lawrie, S M ^b   Mishara, A ^c   Bauer, M ^d   Gallinat, J ^e   Juckel, G ^f   Lang, U ^g   Rapp, M ^h   Falkai, P ⁱ   Strik, W ^j   Krystal, J ^k   Abi Dargham, A ^l   Galderisi, S ^m  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY   (United States)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f RUHR UNIVERSITY BOCHUM   (Germany)

^g UNIVERSITY OF BASEL   (Switzerland)

^h UNIVERSITY OF POTSDAM   (Germany)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^j UNIVERSITY OF BERN   (Switzerland)

^k YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Och Spine at New York Presbyterian Hospitals   (United States)

^m SECOND UNIVERSITY OF NAPLES   (Italy)

more..

Author keywords

DSM; First rank symptoms; ICD; Schizophrenia; Self disorder

Indexed keywords

ANTHROPOLOGY; FIRST RANK SYMPTOM; HUMAN; MENTAL DISEASE; NEUROBIOLOGY; PHENOMENOLOGY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; SCHIZOPHRENIA; SHORT SURVEY; SYMPTOM ASSESSMENT; CLASSIFICATION; DELUSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; INTERNATIONAL CLASSIFICATION OF DISEASES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

DELUSIONS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DISORDERS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPATHOLOGY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84982142878     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2016.04.010     Document Type: Short Survey

References (66)

1. [1] Diagnostic and Statistical Manual of Mental Disorders – (DSM-IV). 4th ed., 1994, American Psychiatric Association, Washington D.C.
2. [2] Tandon, R., Gaebel, W., Barch, D.M., Bustillo, J., Gur, R.E., Heckers, S., et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res 150 (2013), 3–10.
3. [3] World Health Organization, The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. 1992.
4. [4] Peralta, V., Cuesta, M.J., Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. Br J Psychiatry 174 (1999), 243–248.
5. [5] Ihara, K., Morgan, C., Fearon, P., Dazzan, P., Demjaha, A., Lloyd, T., et al. The prevalence, diagnostic significance and demographic characteristics of Schneiderian first-rank symptoms in an epidemiological sample of first-episode psychoses. Psychopathology 42 (2009), 81–91.
6. [6] Schneider, K., Psychischer Befund und psychiatrische Diagnose. 1942, Leipzig, Thieme.
7. [7] Schneider, K., Clinical Psychopathology. (translation by M Hamilton of Klinische Psychopathologie), 5th ed., 1958, Grune and Stratton, New York.
8. [8] Mellor, C.S., First rank symptoms of schizophrenia. I. The frequency in schizophrenics on admission to hospital. II. Differences between individual first rank symptoms. Br J Psychiatry 117 (1970), 15–23.
9. [9] Cutting, J., First rank symptoms of schizophrenia: their nature and origin. Hist Psychiatry 26 (2015), 131–146.
10. [10] Bobon, D.P., The AMDP-system in Pharmacopsychiatry. 1983, S. Karger, AG (Switzerland).
11. [11] Ichstörung Spitzer, M., In Search of a Theory. Spitzer, M., Uehlein, F.A., Oepen, G., (eds.) Psychopathology and philosophy, 1988, Springer, Berlin, Heidelberg, 167–183.
12. [12] Jaspers, K., Hoenig, J., Hamilton, M.W., General Psychopathology. 1997, JHU Press.
13. [13] Bell, V., Halligan, P.W., Ellis, H.D., Diagnosing delusions: a review of inter-rater reliability. Schizophr Res 86 (2006), 76–79.
14. [14] Flaum, M., Arndt, S., Andreasen, N.C., The reliability of “bizarre” delusions. Compr Psychiatry 32 (1991), 59–65.
15. [15] Andreasen, N.C., Carpenter, W.T., Diagnosis and classification of schizophrenia. Schizophr Bull 19 (1993), 199–214.
16. [16] Oliva, F., Dalmotto, M., Pirfo, E., Furlan, P.M., Picci, R.L., A comparison of thought and perception disorders in borderline personality disorder and schizophrenia: psychotic experiences as a reaction to impaired social functioning. BMC Psychiatry, 14, 2014, 239.
17. [17] McGrath, J.J., Saha, S., Al-Hamzawi, A., Alonso, J., Bromet, E.J., Bruffaerts, R., et al. Psychotic experiences in the general population. JAMA Psychiatry, 2015, 1–9.
18. [18] Rössler, W., Ajdacic-Gross, V., Haker, H., Rodgers, S., Müller, M., Hengartner, M.P., Subclinical psychosis syndromes in the general population: results from a large-scale epidemiological survey among residents of the canton of Zurich, Switzerland. Epidemiol Psychiatr Sci 24 (2015), 69–77.
19. [19] van Os, J., Linscott, R.J., Myin-Germeys, I., Delespaul, P., Krabbendam, L., A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 39 (2009), 179–195.
20. [20] Lambo, T., The role of cultural factors in paranoid psychosis among the Yoruba tribe. J Ment Sci 101 (1955), 239–266.
21. [21] Heinz, A., Bermpohl, F., Frank, M., Construction and interpretation of self-related function and dysfunction in Intercultural Psychiatry. Eur Psychiatry 27:Suppl. 2 (2012), S32–S43.
22. [22] Carpenter, W.T., Strauss, J.S., Muleh, S., Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry 28 (1973), 847–852.
23. [23] Kraepelin, E., Psychiatrie – Ein Lehrbuch für Studierende und Ärzte. 5th Ed., 1896, Leipzig, Barth.
24. [24] Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee, S.H., Ripke, S., Neale, B.M., Faraone, S.V., Purcell, S.M., et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet 45 (2013), 984–994.
25. [25] Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381 (2013), 1371–1379.
26. [26] Ruderfer, D.M., Fanous, A.H., Ripke, S., McQuillin, A., Amdur, R.L., Schizophrenia Working Group of Psychiatric Genomics Consortium. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry 19 (2014), 1017–1024.
27. [27] Frith, C.D., Blakemore, S., Wolpert, D.M., Explaining the symptoms of schizophrenia: abnormalities in the awareness of action. Brain Res Brain Res Rev 31 (2000), 357–363.
28. [28] Nelson, B., Fornito, A., Harrison, B.J., Yücel, M., Sass, L.A., Yung, A.R., et al. A disturbed sense of self in the psychosis prodrome: linking phenomenology and neurobiology. Neurosci Biobehav Rev 33 (2009), 807–817.
29. [29] Insel, T.R., The NIMH Research Domain Criteria (RDoC) Project: precision medicine for psychiatry. Am J Psychiatry 171 (2014), 395–397.
30. [30] Hägele, C., Schlagenhauf, F., Rapp, M., Sterzer, P., Beck, A., Bermpohl, F., et al. Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders. Psychopharmacology (Berl) 232 (2014), 331–341.
31. [31] Wang, X.-J., Krystal, J.H., Computational psychiatry. Neuron 84 (2014), 638–654.
32. [32] Vosgerau, G., Voss, M., Authorship and control over thoughts. Mind & Language, 2014, 10.1111/mila.12065/full.
33. [33] Wakefield, J.C., The concept of mental disorder: diagnostic implications of the harmful dysfunction analysis. World Psychiatry 6 (2007), 149–156.
34. [34] Heinz, A., Der Begriff der psychischen Krankheit. 2014, Suhrkamp Verlag.
35. [35] Sartorius, N., Meta effects of classifying mental disorders. The Conceptual Evolution of DSM-5. 2011.
36. [36] Nordgaard, J., Arnfred, S.M., Handest, P., Parnas, J., The diagnostic status of first-rank symptoms. Schizophr Bull 34 (2008), 137–154.
37. [37] Soares-Weiser, K., Maayan, N., Bergman, H., Davenport, C., Kirkham, A.J., Grabowski, S., et al. First rank symptoms for schizophrenia. Cochrane Database Syst Rev, 2015, CD010653.
38. [38] Marneros, A., Schizophrenic first-rank symptoms in organic mental disorders. Br J Psychiatry 152 (1988), 625–628.
39. [39] Heinz, A., Przuntek, H., Winterer, G., Pietzcker, A., [Clinical aspects and follow-up of dopamine-induced psychoses in continuous dopaminergic therapy and their implications for the dopamine hypothesis of schizophrenic symptoms]. Nervenarzt 66 (1995), 662–669.
40. [40] Sass, L.A., Madness and modernism. 1992, Basic Books.
41. [41] Zarrouk, E.T., The usefulness of first-rank symptoms in the diagnosis of schizophrenia in a Saudi Arabian population. Br J Psychiatry 132 (1978), 571–573.
42. [42] Coffey, G.J., Mackinnon, A., Minas, I.H., Interethnic variations in the presence of Schneiderian first rank symptoms. Aust N Z J Psychiatry 27 (1993), 219–227.
43. [43] Hutchinson, G., Takei, N., Sham, P., Harvey, I., Murray, R.M., Factor analysis of symptoms in schizophrenia: differences between White and Caribbean patients in Camberwell. Psychol Med 29 (1999), 607–612.
44. [44] Napo, F., Heinz, A., Auckenthaler, A., Explanatory models and concepts of West African Malian patients with psychotic symptoms. Eur Psychiatry 27:Suppl. 2 (2012), S44–S49.
45. [45] Chandrasena, R., Schneider's first rank symptoms: an international and interethnic comparative study. Acta Psychiatr Scand 76 (1987), 574–578.
46. [46] Klee, E., Dokumente zur » Euthanasie « im NS-Staat. 6th ed., 2006, Fischer Taschenbuch Verlag, Frankfurt am Main.
47. [47] Levine, S.Z., Levav, I., Goldberg, Y., Pugachova, I., Becher, Y., Yoffe, R., Exposure to genocide and the risk of schizophrenia: a population-based study. Psychol Med 46 (2016), 855–863.
48. [48] Bleuler, E., Dementia praecox oder Gruppe der Schizophrenien. Handbuch der psychiatrie, 1911.
49. [49] Swiney, L., Sousa, P., When our thoughts are not our own: investigating agency misattributions using the mind-to-mind paradigm. Conscious Cogn 22 (2013), 589–602.
50. [50] Blakemore, S.J., Wolpert, D.M., Frith, C.D., Abnormalities in the awareness of action. Trends Cogn Sci 6 (2002), 237–242.
51. [51] Voss, M., Moore, J.W., Hauser, M., Gallinat, J., Heinz, A., Haggard, P., Altered awareness of action in schizophrenia: a specific deficit in predicting action consequences. Brain 133 (2010), 3104–3112.
52. [52] Plessner, H., Die Stufen des Organischen und der Mensch. Einleitung in die philosophische Anthropologie (3. Unveränd.). 1975, Walter de Gruyter, Berlin.
53. [53] Sass, L.A., Parnas, J., Schizophrenia, consciousness, and the self. Schizophr Bull 29 (2003), 427–444.
54. [54] Mishara, A.L., Lysaker, P.H., Schwartz, M.A., Self-disturbances in schizophrenia: history, phenomenology, and relevant findings from research on metacognition. Schizophr Bull 40 (2014), 5–12.
55. [55] Spiegel, D., Loewenstein, R.J., Lewis-Fernandez, R., Sar, V., Simeon, D., Vermetten, E., et al. Dissociative disorders in DSM-5. Depression Anxiety, 28(12), 2011.
56. [56] Frith, C.D., The Cognitive Neuropsychology of Schizophrenia (Classic Edition). 2015, Psychology Press.
57. [57] Parnas, J., Handest, P., Phenomenology of anomalous self-experience in early schizophrenia. Compr Psychiatry 44 (2003), 121–134.
58. [58] Pankow, A., Katthagen, T., Diner, S., Deserno, L., Boehme, R., Kathmann, N., et al. Aberrant salience is related to dysfunctional self-referential processing in psychosis. Schizophr Bull, 2015, 10.1093/schbul/sbv098.
59. [59] Nelson, B., Whitford, T.J., Lavoie, S., Sass, L.A., What are the neurocognitive correlates of basic self- disturbance in schizophrenia?: integrating phenomenology and neurocognition. Part 1 (source monitoring deficits). Schizophr Res 152:1 (2013), 12–19.
60. [60] Nelson, B., Whitford, T.J., Lavoie, S., Sass, L.A., What are the neurocognitive correlates of basic self-disturbance in schizophrenia?: integrating phenomenology and neurocognition: part 2 (aberrant salience). Schizophr Res 152:1 (2013), 20–27.
61. [61] Frith, C.D., The Cognitive Neuropsychology of Schizophrenia. 1992, Erlbaum/Taylor and Francis, East Sussex, England.
62. [62] Synofzik, M., Vosgerau, G., Voss, M., The experience of agency: an interplay between prediction and postdiction. Front Psychol, 4, 2013, 127.
63. [63] Hauser, M., Knoblich, G., Repp, B.H., Lautenschlager, M., Gallinat, J., Heinz, A., et al. Altered sense of agency in schizophrenia and the putative psychotic prodrome. Psychiatry Res, 186(2-3) 2010, 170-6.
64. [64] Bonhoeffer, K., Die exogenen reaktionstypen. Archiv für Psychiatrie und Nervenkrankheiten 58 (1917), 58–70.
65. [65] Gaebel, W., Zielasek, J., Cleveland, H.-R., Classifying psychosis – challenges and opportunities. Int Rev Psychiatry 24 (2012), 538–548.
66. [66] Tandon, R., Bruijnzeel, D., Rankupalli, B., Does change in definition of psychotic symptoms in diagnosis of schizophrenia in DSM-5 affect caseness?. Asian J Psychiatr 6 (2013), 330–332.